Deborah Soong

@RubenRuizVegaMD @FLASCO_ORG So nice to meet you!! Lots of opportunities for collaboration in the near future!

Pleasure meeting my newest #FLASCOfellow @DeborahSoong! Thank you @FLASCO_ORG for a great conference!

Did you know there are currently mRNA vaccines in the works for sarcoma? One just opened for osteosarcoma at UF? I learned about this from my new friends at @FLASCO_ORG #FLASCOfellows

New friends at the exhibition at @FLASCO_ORG #FLASCOfellow

@elonmusk Same with hospital admin at hospitals

Makes no sense

@HouseLyndseyRN Do you know why she needed the 3 vaccines? Because PNH with abnormal CD55 and CD59 means she can’t fight off certain infections. We have a ton of patients with PNH who’ve all been vaccinated. It is very unfortunate that she developed this reaction, but it is extremely rare.

yall she went to hospital to be treated for PNH which is a blood disorder- her hemoglobin was 3.1 and they gave her blood to bring it back up 📢📢🚨🚨 i guarantee you the blood they gave her prob had spike protein in it- even though red cross says they check prior i am calling that a huge LIE the specialist saw her after and stated before she could treat her PNH she was required to get those three vaccines- she took em and within minutes this is what happened

😭😭😭😭😭 please pray for this sweet girl💜💜 she had reaction to : meningitis, pneumonia and tetanus vax all given at once😭😭 she’s getting worse😭

@flasco has been an eye opening experience . Today I learned that there are many resources through @society_florida to discover other aspects of heme/onc that are just as important as clinical oncology, such as advocacy, policy, and community outreach. #flascofellow

Our latest ➡️ Methotrexate-Induced Subacute Combined Degeneration in Acute Lymphoblastic Leukemia with CNS Relapse May Be Reversible mdpi.com/2520654 #mdpihemato via @Hemato_MDPI #leusm @SylvesterCancer @JustinWattsMD @DeborahSoong @Ellen_cve Wenhui Li & David Dukenik

In this editorial, @DeborahSoong and @TaylorJ_MD review the recently published trial on vemurafenib and obinutuzumab as therapy for hairy cell leukemia and discuss the potential impact and limitations of this combination. Read the editorial: eviden.cc/44WCKHw

This link should give free access: evidence.nejm.org/doi/full/10.10… Thanks to @DeborahSoong, as always it was a pleasure to work together on this! @SylvesterCancer

@RajitaKumarMD @CrohnsColitisFn Love this!! Making those steps count!

@vkittipibul @vbluml @md_chaparro @GHernandezMD @UmJmhIMRes Fabulous as always!

It is such a great honor to present my research journey on AF and LVADs during UM DOM Grand Round! Couldn't be more grateful for your continued support! @vbluml @md_chaparro @GHernandezMD @UmJmhIMRes